Test Price
2,800 AEDโ Home Collection Available
WDR35 Gene (Cranioectodermal Dysplasia Type 2) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Core Guarantees
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance to interpret your results with a genetic specialist.
- Insurance: Direct Billing Verification via WhatsApp at +971545488731.
Test Overview & Methodology
The WDR35 Gene Genetic Test screens for pathogenic variants associated with Cranioectodermal Dysplasia Type 2 (CED2), a rare ciliopathy characterized by skeletal abnormalities, ectodermal defects, and renal involvement. This advanced Next-Generation Sequencing analysis offers definitive molecular diagnosis, guiding pediatric management and genetic counseling.
Our Test vs. Closest Alternative
| Feature | Our WDR35 NGS Test | Targeted Variant Panel |
|---|---|---|
| Precision | Full gene sequencing & deletion/duplication analysis | Only known hotspots; may miss novel mutations |
| Methodology | Next-Generation Sequencing (NGS) with bioinformatic validation | Sanger sequencing or limited MLPA |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks (often outsourced) |
Physician Insight & Safety Protocols
โCranioectodermal dysplasia type 2 is a complex multisystem disorder where genotype-phenotype correlation is critical; this NGS test provides the molecular confirmation necessary to tailor surveillance and family planning. As a clinician, I strongly recommend that results be interpreted in the context of comprehensive clinical evaluation, never in isolation.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Precautions
โ ๏ธ Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace ongoing medical management.
Safety & Exclusion Criteria
Sample Rejection & Patient Exclusion
- Sample Rejection: Grossly hemolyzed, clotted, or incorrectly stored whole blood samples will be rejected.
- Patient Exclusion: Individuals currently receiving heparin therapy (use alternative anticoagulant collection) or those who have undergone hematopoietic stem cell transplant within 90 days; results may be confounded.
- Emergency Red Flags: If you or your child experience acute renal colic, sudden vision loss, or severe respiratory distress, seek immediate emergency care โ do not wait for test results. This test is not a substitute for urgent evaluation.
Patient FAQ & Clinical Guidance
1. What does the WDR35 genetic test detect and why is family history important?
The test identifies pathogenic variants in the WDR35 gene that cause cranioectodermal dysplasia type 2, a condition inherited in an autosomal recessive manner; therefore, a detailed pedigree helps assess carrier status and recurrence risk for future pregnancies.
2. How is the sample collected and what are the accepted sample types?
We accept whole blood, extracted DNA, or a one-drop dried blood spot on an FTA card; a certified phlebotomist will perform painless home collection using ISO cold-chain transport to preserve DNA integrity.
3. Is a genetic counseling session mandatory before testing?
Pre- genetic counseling is mandatory to document the clinical history, construct a pedigree, and ensure informed consent; our service includes this session at no extra cost, conducted virtually via telehealth in English or Arabic.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance
This test is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient genetic data is encrypted, anonymized, and stored securely. Results are shared only with the ordering physician and patient upon consent. Additionally, all clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | WDR35 Gene (Cranioectodermal Dysplasia Type 2) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) with bioinformatic validation |
| ICD-10-CM Code | Q87.8 (Other specified congenital malformation syndromes) |
| LOINC Code | 90369-8 (WDR35 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians